JCI - Heterologous prime-boost vaccination protects against EBV antigen–expressing lymphomas
COVID-19: safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine (Sputnik V)
Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses: Molecular Therapy - Oncolytics
Frontiers | Can Complementary Prime-Boost Immunization Strategies Be an Alternative and Promising Vaccine Approach Against Dengue Virus?
Evaluation of heterologous prime-boost vaccination strategies using chimpanzee adenovirus and modified vaccinia virus for TB subunit vaccination in rhesus macaques | npj Vaccines
The adidas adiZero Prime Boost Gets Another Versatile Finish • KicksOnFire.com
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data - The Lancet
The mechanism of prime-boosting in relation to PD-1-expression and... | Download Scientific Diagram
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice | Signal Transduction and Targeted Therapy
Schematic illustrating the prime-boost concept. Note: High levels of... | Download Scientific Diagram
Homologous prime-boost strategy with TgPI-1 improves the immune response and protects highly susceptible mice against chronic Toxoplasma gondii infection - ScienceDirect
adidas adiZero Prime Boost - WearTesters
How the Interval between Prime and Boost Injection Affects the Immune Response in a Computational Model of the Immune System
Frontiers | Optimize Prime/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game
Frontiers | Heterologous Prime-Boost Vaccination Enhances TsPmy's Protective Immunity against Trichinella spiralis Infection in a Murine Model
Does the immunization order of vaccine types influence the efficacy of heterologous prime-boost vaccination, especially mRNA and protein-based vaccines?
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 | npj Vaccines
Heterologous Prime Boost Vaccination Induces Protective Melanoma-Specific CD8+ T Cell Responses: Molecular Therapy - Oncolytics
Heterologous prime-boost vaccination against tuberculosis with recombinant Sendai virus and DNA vaccines | SpringerLink
Heterologous Prime-Boost Enhances the Antitumor Immune Response Elicited by Plant-Virus-Based Cancer Vaccine | Journal of the American Chemical Society
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study - The Lancet Respiratory Medicine
Relevance of long-lived CD8+ T effector memory cells for protective immunity elicited by heterologous prime-boost vaccination | Semantic Scholar
Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy | Journal for ImmunoTherapy of Cancer
Cancers | Free Full-Text | Heterologous Prime-Boost Vaccination with a Peptide-Based Vaccine and Viral Vector Reshapes Dendritic Cell, CD4+ and CD8+ T Cell Phenotypes to Improve the Antitumor Therapeutic Effect
